New target for Parkinson’s treatment

Tel Aviv University researchers have discovered a mutation of the TMEM16F protein secretes α-synuclein to enhance the spread of Parkinson’s pathology through nerve cells in the brain. Blocking or modulating TMEM16F activity may reduce α-synuclein and cure Parkinson’s disease.

https://tps.co.il/articles/researchers-identify-key-protein-in-parkinsons-disease-spread/

https://onlinelibrary.wiley.com/doi/full/10.1111/acel.14387

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *